CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $426.40 | $213K | 130 |
| 2025-10-24 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 154,000 | ||
| 2025-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,500 | $421.63 | $1.1M | 1,630 |
| 2025-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $422.58 | $423K | 630 |
| 2025-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $424.16 | $212K | 130 |
| 2025-10-23 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 158,000 | ||
| 2025-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −634 | $420.47 | $267K | 3,496 |
| 2025-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,200 | $422.15 | $929K | 1,296 |
| 2025-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,166 | $423.07 | $493K | 130 |
| 2025-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 162,000 | ||
| 2025-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,088 | $425.38 | $463K | 3,042 |
| 2025-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,412 | $426.18 | $602K | 1,630 |
| 2025-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $430.35 | $430K | 630 |
| 2025-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $432.20 | $216K | 130 |
| 2025-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 166,000 | ||
| 2025-10-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $135.42 | $2.0M | 14,625 |
| 2025-10-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14,625 | $427.41 | $6.3M | 0 |
Page 190 of 214 · 4,273 trades